| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $349K | -88.9% |
| SG&A Expense | $5.7M | -48.3% |
| Operating Income | -$2.5M | +87.4% |
| Interest Expense | $0 | — |
| Pre-tax Income | $149.0M | +877.9% |
| Income Tax | $0 | +100.0% |
| Net Income | $149.0M | +886.2% |
| EPS (Basic) | $0.64 | +288.2% |
| EPS (Diluted) | $0.64 | +288.2% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $6.4M | -23.1% |
| Current Assets | $7.1M | -29.1% |
| Total Assets | $7.2M | -28.8% |
| Current Liabilities | $645K | -61.3% |
| Total Liabilities | $645K | -99.6% |
| Stockholders' Equity | $4.0M | +102.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.0M | +50.2% |
| Investing Cash Flow | $3.5M | +7708.7% |
| Financing Cash Flow | $635K | -71.4% |